反応式
OC[C@@]12[C@@H]3[C@H]([C@H]4[C@@](CC3)(C)C=CC4)CCC1CCCC2.ClC1C(=O)C(C#N)=C(C#N)C(=O)C=1Cl.[OH:35][CH2:36][C@@:37]12[C@@H:54]3[C@H:45]([C@H:46]4[C@@:50]([CH2:52][CH2:53]3)([CH3:51])[CH2:49][CH2:48][CH2:47]4)[CH2:44][CH2:43][C:42]1=[CH:41][C:40](=[O:55])[CH2:39][CH2:38]2.O1CCOCC1>C(Cl)Cl>[OH:35][CH2:36][C@@:37]12[C@@H:54]3[C@H:45]([C@H:46]4[C@@:50]([CH2:52][CH2:53]3)([CH3:51])[CH2:49][CH2:48][CH2:47]4)[CH2:44][CH2:43][C:42]1=[CH:41][C:40](=[O:55])[CH:39]=[CH:38]2参加物
実験手順
The 1,4 and 6-methylated derivatives for the 4-androstene-3, 19-diones of the present invention are best prepared by introducing the desired methyl group into the 19-hydroxy-androstene and oxidizing the 19-alcohol to the aldehyde. The 1α-methyl-19-hydroxy-4-androsten-3-ones which can be oxidized to the aldehydes are prepared in two steps. The reaction of dichlorodicyanobenzoquinone with a 19-hydroxy-4-androsten-3-one in refluxing dioxane or methylenechloride for 24-72 hours to produce the corresponding 19-hydroxy-1,4-androstadien-3-one. However, two restrictions in this sequence are necessary. First, the 19-hydroxy group must be protected as an ester or an ether in order to avoid aromatization. Secondly, the 1-position must possess an axial hydrogen atom suitable for elimination. Thus, the 1α-methyl androstene is not reactive although the 1β-methyl androstane is. Following this procedure 17β,19-dihydroxy-7α-methyl-4-androsten-3-one dipropionate is converted to 17β,19-dihydroxy-7α-methyl-1,4-androstadien-3-one dipropionate. Similarly, 19-hydroxy-6α-methyl-4-androstene-3,17-dione acetate forms 19-hydroxy-6α-methyl-1,4-androstadiene-3,17-dione acetate and 1β-methyl-19-tetrahydropyranyloxy-4-androstene-3,17-dione forms 1-methyl-19-tetrahydropyranyloxy-1,4-androstadiene-3,17-dione.
後処理
- customare prepared in two steps
出典と根拠
- ORDレコード
- ord-e9b4d56b1a0c4f598ff4a3ca483124b0
- 出典データセット
- uspto-grants-1978_01
- 特許番号
- US04071624
関連ノート
読み込み中…